• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Leveraged finance

healthcare-stethoscope
Singapore's Quadria secures $200m 'social' credit facility

Singapore-based healthcare specialist Quadria Capital has secured a revolving credit facility of up to USD 200m for investments deemed “social projects.”

  • Southeast Asia
  • 11 August 2023
pills-drugs-pharma-3
PE-owned Japanese drug maker seeks bankruptcy protection

Kyowa Pharmaceutical Industry, a Japanese generic drug manufacturer owned by Unison Capital, has applied for alternative dispute resolution, an out-of-court process that allows companies to continue operations while negotiating with creditors on a restructuring.

  • North Asia
  • 07 August 2023
money-balance-leverage-coins
Asia deal financing: A selective market

Regional buyout activity is weak but leveraged loans are available for the right kind of target – in Japan, Korea, Australia, and beyond – and with a suitably customised structure

  • North Asia
  • 26 July 2023
xray-diagnostic-image-radiology-05
Australia's GenesisCare files for US bankruptcy protection

GenesisCare, an Australia-headquartered cancer care provider in which KKR holds a minority stake, has filed for bankruptcy protection in the US and announced a restructuring that will separate US operations from those in Australia, Spain, and the UK.

  • Australasia
  • 02 June 2023
pet-food-dog-03
Australia’s Real Pet Food taps investors for equity injection

Hosen Capital, New Hope Group, and Temasek Holdings have led a AUD 248m (USD 161.2m) equity injection into Australia-based chilled pet food supplier Real Pet Food to pay down debt and support growth.

  • Australasia
  • 01 June 2023
dollar-money-jigsaw-puzzle
BPEA EQT seeks financing for Vistra, Tricor merger

BPEA EQT is pushing ahead with the merger of Asia-headquartered corporate services providers Vistra Group and Tricor Group, having initiated discussions on pricing a USD 1.66bn financing package.

  • Buyouts
  • 22 March 2023
wound-bandage-dressing-plaster
Deal focus: GL Capital plots careful China carve-out

GL Capital worked quietly but industriously to secure a leveraged buyout of China-based contract manufacturer Foryou Medical Devices – even using renminbi financing to avoid US dollar interest rate exposure

  • Greater China
  • 21 March 2023
avcj-australia-2023-global
GPs double down on value creation to maintain returns - AVCJ Forum

Private equity investors must find more operational levers to pull as LPs seek the same if not higher returns from the asset class despite more challenging economic conditions.

  • Australasia
  • 17 March 2023
2023 preview: Buyouts

Even though debt is more readily available in Asia than in the US or Europe, financing costs are up, and buyout investors are reluctant to move for assets in an uncertain and overvalued market

  • Buyouts
  • 14 December 2022
david-gross-loh-bain-2022
Q&A: Bain Capital’s David Gross-Loh

David Gross-Loh, a managing director and a founding member of the Asia business at Bain Capital, on expanding into Osaka, targeting large-cap carve-outs in Japan, and the availability of deal financing

  • North Asia
  • 14 December 2022
dollar-money-jigsaw-puzzle
Deal financing: Homegrown solutions

Private equity firms are relying more heavily on Asia-based debt investors to support leveraged buyouts amid a loan logjam in the US, highlighting the region’s innovation and durability

  • Australasia
  • 07 September 2022
2022-australia-conf-issue-cover
AVCJ Australia & New Zealand Forum 2022 special issue

  • Australasia
  • 13 June 2022
size-large-hanger
Australia take-privates: Going large

A combination of abundant dry powder and friendly financing conditions are encouraging global GPs to pursue ever-larger listed companies in Australia. For now, macro headwinds are no deterrent

  • Australasia
  • 24 May 2022
esg-cogs-mechanism-leverage-sustainability
Leveraged finance: ESG sells

Private equity firms in Asia are increasingly willing to consider sustainability-linked credit facilities, and banks are generally happy to provide them. Speed is currently delaying standardisation

  • Financing
  • 23 March 2022
Baring Asia completes $386m recap of CitiusTech

Baring Private Equity Asia (BPEA) has completed a USD 385.9m dividend recap and refinancing of loans tied to its 2019 acquisition of India-based healthcare IT services business CitiusTech.

  • South Asia
  • 01 March 2022
TPG-owned clinical trials player raises new equity, debt

Novotech, an Asia-based clinical trials specialist controlled by TPG Capital, has secured USD 760m in new equity and debt financing at a post-deal valuation of approximately USD 3bn.

  • Australasia
  • 20 January 2022
seed-funding-venture-money-plant-02
Baring Asia creates sustainability-linked credit facility

Baring Private Equity Asia (BPEA) has secured a $3.2 billion loan to support its private equity platform with interest rate reductions linked to performance against a series of sustainability metrics.

  • Financing
  • 15 October 2021
tourism-tourist-holiday
Asia travel & hospitality: Ready to board?

The outlook for international tourism remains uncertain, but this hasn’t stopped some private equity and venture capital investors targeting travel and hospitality assets in Asia. It pays to be selective

  • Greater China
  • 09 December 2020
Asia buyout returns: Spoilt for choice?

Fund managers believe the ability to finance and refinance deals on attractive terms, as well as a wider array of paths to liquidity, will underpin performance in Asia

  • Buyouts
  • 30 November 2020
dollar-crack-fracture-distress-break-money
Coronavirus & leverage: Room to maneuver?

Economic disruption caused by the coronavirus outbreak is likely to leave many private equity portfolio companies in breach of their leverage covenants. Borrowers and lenders are looking for a fix

  • Financing
  • 25 March 2020
avcj-australia-2020-private-debt
Macro factors not slowing private debt in Australia - AVCJ Forum

Leveraged lenders focusing on Australia and New Zealand continue to see strong demand from financial sponsors, with the impact of global macroeconomic volatility likely to be delayed and perhaps muted.

  • Australasia
  • 09 March 2020
Australia leveraged finance: Best blend?

Two years ago, unitranche structures were a novelty in Australia’s leveraged finance market. Now they are an integral part of it. For borrowers and lenders, there might be no turning back

  • Australasia
  • 25 September 2019
Asia leveraged finance: Institutional aspirations

PE firms can obtain financing for leveraged buyouts in Asia on increasingly favorable terms, but this doesn’t necessarily point to institutionalization – or at least, not yet. For now, banks still lead the way

  • Financing
  • 27 September 2018
LPs warn of impending downturn in Asia

Institutional investors are preparing for a downturn in Asia – and emphasizing the importance of disciplined deployment – as they see worrying “pro-cycle market behavior” in the private markets space globally.

  • Greater China
  • 06 June 2018
1 2 3
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013